BioRestorative Therapies Inc [NASDAQ: BRTX] jumped around 0.65 points on Monday, while shares priced at $3.45 at the close of the session, up 23.21%. The company report on February 5, 2024 at 7:30 AM that BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease.
— Preliminary data includes 26 and 52-week follow-up end points as part of ongoing Phase 2 trial —.
— Company to host webcasted conference call today at 8:30am EST —.
Compared to the average trading volume of 39.58K shares, BRTX reached a trading volume of 18794129 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about BioRestorative Therapies Inc [BRTX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BRTX shares is $10.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BRTX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for BioRestorative Therapies Inc is set at 0.27, with the Price to Sales ratio for BRTX stock in the period of the last 12 months amounting to 125.00. The Price to Book ratio for the last quarter was 1.26, with the Price to Cash per share for the same quarter was set at 2.60.
How has BRTX stock performed recently?
BioRestorative Therapies Inc [BRTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 121.15. With this latest performance, BRTX shares gained by 97.14% in over the last four-week period, additionally plugging by 21.91% over the last 6 months – not to mention a rise of 10.22% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BRTX stock in for the last two-week period is set at 87.83, with the RSI for the last a single of trading hit 92.88, and the three-weeks RSI is set at 82.57 for BioRestorative Therapies Inc [BRTX]. The present Moving Average for the last 50 days of trading for this stock 1.82, while it was recorded at 2.33 for the last single week of trading, and 2.88 for the last 200 days.
BioRestorative Therapies Inc [BRTX]: Deeper insight into the fundamentals
BioRestorative Therapies Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 13.51 and a Current Ratio set at 13.51.
Earnings analysis for BioRestorative Therapies Inc [BRTX]
With the latest financial reports released by the company, BioRestorative Therapies Inc posted -1.19/share EPS, while the average EPS was predicted by analysts to be reported at -1.43/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 16.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BRTX.
Insider trade positions for BioRestorative Therapies Inc [BRTX]
The top three institutional holders of BRTX stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in BRTX stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in BRTX stock with ownership which is approximately 5.8325%.
